Opioid withdrawal and mental health concerns need a connected plan. Relief of the immediate withdrawal symptoms is only one part of care. The team also needs to assess the pattern of opioid use, current psychiatric symptoms, pain, other substances, and what treatment will remain available after the initial episode ends.
This matters because a person can leave a short period of withdrawal care with unresolved depression, no confirmed medication follow-up, and no practical way to obtain continuing treatment. The aim is to prevent those gaps while respecting the person’s preferences and the clinical reasons for each decision. This guide describes questions for professional assessment; it does not provide a home withdrawal or medication-starting schedule.
Clarify what is being assessed
Physical dependence, withdrawal, and opioid use disorder are related concepts, but they are not interchangeable labels. Someone taking prescribed opioids may experience withdrawal after a change without that fact alone establishing an opioid use disorder. Assessment should examine the wider pattern and consequences of use rather than infer a diagnosis from one symptom.
Tell the clinician the names of prescribed and nonprescribed substances, how they have been used, the most recent use, and any recent medication changes. If the contents of a nonprescribed substance are uncertain, say so. Include treatment received elsewhere, prior overdose, withdrawal experiences, pain diagnoses, and previous psychiatric care.
The medication review guide can help prepare an accurate account. The purpose is to support safer decisions, not to require a perfect history before help is available. Bring packaging or a current list if that is feasible, and identify any details that still need confirmation.
Keep immediate safety separate from the longer assessment
If someone is difficult to wake, is breathing abnormally or very slowly, collapses, or may be experiencing an overdose, call emergency services immediately. Use available naloxone according to its instructions and emergency guidance. Do not wait for an addiction appointment or assume the person simply needs to sleep.
Severe confusion, a seizure, suicidal intent, or inability to remain safe also requires urgent assessment. These concerns should not be postponed until the withdrawal phase is considered complete. Tell the team about alcohol and sedatives because the overall safety assessment must consider more than opioids.
For less immediately dangerous but worsening symptoms, contact the treating service promptly and explain what has changed. Ask in advance which number to use during office hours and what route applies outside them. A routine follow-up address should not be assumed to provide emergency response.
Understand why detox alone is an incomplete opioid use disorder plan
The CDC advises against detoxification alone, without medication treatment, for opioid use disorder because of increased risks of returning to use, overdose, and overdose death. It identifies buprenorphine, methadone, and naltrexone as FDA-approved medications for treating opioid use disorder. Source: CDC guidance on treating opioid use disorder.
That guidance does not mean every person should receive the same medication or begin it in the same way. Selection and initiation require an appropriately qualified clinician who can consider current opioid exposure, health, other medication, treatment history, preferences, and access to follow-up.
Ask what the proposed withdrawal intervention is intended to achieve and how it connects with ongoing treatment. If the proposal ends when immediate symptoms improve, ask who will discuss the next phase before discharge. A destination for further care should be confirmed rather than left as an instruction to find help later.
Review mood and anxiety without assuming one cause
Low mood, anxiety, sleep disruption, distress, and difficulty concentrating can have several contributors during a change in opioid use. They may relate to withdrawal, pain, an existing mental health condition, medication effects, life circumstances, or a combination. A clinician needs the history and the changing pattern to interpret them.
SAMHSA’s guidance on co-occurring disorders emphasizes ongoing reassessment when substance-related and independent psychiatric symptoms overlap. A provisional explanation can guide initial care while further observation clarifies the picture. Source: SAMHSA TIP 42, Chapter 4.
Describe when symptoms began, whether they existed before the current opioid pattern, and what occurred during previous periods of stability. Explain how they affect eating, sleep, self-care, relationships, and safety. These details are more useful than trying to decide on a diagnosis yourself.
Uncertainty about the final diagnosis should not become a reason to ignore suffering or risk. Ask what support is appropriate now, which symptoms need specialist review, and when the initial formulation will be reconsidered. The plan can address immediate needs while remaining open to revision.
Avoid making access to one treatment depend on finishing another
Mental health care and treatment for opioid use disorder should be coordinated around current needs. The CDC states that declining psychosocial treatment, or its unavailability, should not prevent or delay medication treatment for opioid use disorder. That is especially relevant when a therapy waiting list is long.
Ask whether the proposed service can provide both components directly or will coordinate with another clinician. If a psychiatrist, addiction prescriber, therapist, and primary care professional are involved, identify who leads the overall plan and how they communicate with authorization.
Consider a practical example: a person can attend medication appointments promptly but cannot start a particular therapy until a later date. The team should explain what support is available in the meantime rather than treat the entire pathway as closed. Similarly, an urgent psychiatric need should be addressed without requiring a completed rehabilitation course first.
Do not overlook prescribed medication and pain
If opioids were prescribed for pain, discuss how pain will be assessed and treated as part of the plan. A change in opioid treatment should not leave the underlying problem unexamined. Describe daily function, previous approaches, current benefits and difficulties, and any medication from other prescribers.
The CDC’s 2022 opioid prescribing guideline cautions against rapid or abrupt discontinuation of long-term opioid therapy except in particular life-threatening circumstances. Its pain recommendations have defined clinical scope and should not be converted into a universal rule for every situation. Source: CDC 2022 clinical practice guideline.
Alcohol, benzodiazepines, and other sedating substances can complicate safety. Give the clinician a full account rather than changing prescribed medication yourself. The same CDC guideline advises that buprenorphine or methadone for opioid use disorder should not be withheld solely because a person uses benzodiazepines or other central nervous system depressants; the combined risks require careful management.
Check the receiving program before arranging a transfer
A residential or mental health program should confirm whether it can continue the agreed opioid use disorder treatment. Ask which medications it supports, who prescribes, how appointments are arranged, and whether an external opioid treatment service must remain involved.
Do not infer capability from the word dual diagnosis. A program may provide psychotherapy for co-occurring conditions while relying on another service for prescribing or a particular level of medical care. Clarify those arrangements before changing location or ending an existing appointment schedule.
If a provider proposes changing a helpful medication solely to fit its standard model, ask for a clinical explanation and discuss it with the current prescriber. The opioid treatment continuity guide develops the questions to ask when services or settings change.
Make the discharge plan usable on the first day
Before departure, identify the next appointment, its location or approved remote format, the receiving clinician, and how records will be transferred. Confirm medication supply and any required pharmacy or treatment-program arrangements. Ask what to do if an appointment is canceled or a medicine cannot be obtained.
Travel can complicate access, particularly across borders. A prescription or treatment arrangement in one place should not be assumed to remain usable elsewhere. Get advice for the actual route and destination before making plans that depend on uninterrupted medication access.
Ask about naloxone access and overdose-response education for the person and, with appropriate involvement, people close to them. The CDC includes these measures in opioid use disorder care. They complement continuing treatment and do not replace emergency assistance when overdose is suspected.
The team should also record unresolved mental health questions, current risk concerns, and who will review them. A discharge note stating that withdrawal has ended is insufficient if psychiatric follow-up remains unassigned.
Give family members a defined supporting role
With the person’s permission and when appropriate, relatives or trusted friends can help with transport, appointment reminders, medication collection, and communicating concerns. Discuss what help is welcome and what information may be shared. Support should not depend on a family member becoming an informal clinician.
Relatives may also need their own explanation of the treatment plan. Ask the team how to respond to worsening symptoms, missed contact, or suspected overdose. Ordinary boundaries and emergency actions should be clear without turning the home into a constant monitoring arrangement.
Review the whole pathway after stabilization
At the next review, consider opioid use, cravings, pain, mood, sleep, medication effects, safety, attendance, and daily functioning together. Ask whether the current intensity is enough and whether practical barriers are undermining a clinically reasonable plan.
The aim is a connected sequence: immediate assessment, appropriate treatment for opioid use disorder when present, mental health care, and a confirmed transition. Stabilization is a useful beginning when it opens access to that continuing pathway and leaves each responsibility with someone able to carry it out.
Sources and further reading
Found a detail that has changed? Tell the editorial team.